The global pegfilgrastim biosimilar market is projected to register considerable growth in between 2020 and 2026. A Fact.MR study shows that coronavirus outbreak has deterred the opportunities in the market for a short term. Wide ranging field of applications in HIV/AIDS will also help in sustaining better growth for years to come.
"Improving healthcare facilities in developed economies like US presents key opportunities for the market players. Major participants have developed biosimilar to focus on cost-efficient cancer research and treatments," says the FACT.MR report.
Gain a comprehensive insight by requesting for a sample at: https://www.factmr.com/connectus/sample?flag=S&rep_id=1494
Pegfilgrastim Biosimilar Market- Key Takeaways
- Owing to extending cancer treatment measures in North America, this region remains the most lucrative amongst the others.
- Strategic collaborations and partnerships will help in product innovation and improved demand to supply ratio.
- Asia Pacific region will continue to remain the fastest growing market for pegfilgrastim biosimilars.
- Regions are currently focussing on reimbursements policies and FDA approvals to gain a prominent market position.
Pegfilgrastim Biosimilar Market - Driving Factors
- Pegfilgrastim is an essential drug for cancer treatments and is used in chemotherapy and radiotherapy neutropenia.
- This medication stimulates the formation of white blood cells in the bone marrow to help the body fight infections.
- Pegfilgrastim biosimilars treats patients with hematopietic subsyndrome of acute radiation syndrome and fuels adoption in pharmaceuticals.
Pegfilgrastim Biosimilar Market - Major Restraints
- Higher costs limits its adoption in the Asia-Pacific region.
- Limited information and awareness regarding the drug acts as a key factor hindering market growth prospects.
COVID-19 Impact on Pegfilgrastim Biosimilar Market
COVID-19 has surely affected clinical trials, which led to delays in the approval process. Delays caused due to pandemic crisis also leads to a backlog of approvals, and eventually delays the product launches. COVID-19 might also increase the number of deaths caused due cancer as the attention is towards the patients affected by the pandemic. Studies show that 28% of COVID-19 patients died with cancer which is two to three times the rate of people without cancer. Advanced healthcare facilities in USA and Europe can drive the market growth there but it's uncertain due to rising number of COVID cases.
For More Detailed Information about Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=1494
Competitive Landscape
Market players are currently focussing on strategic collaborations and partnerships to strengthen their presence. Coherus Biosciences, Mylan N.V., Biocon, and Novartis AG (Sandoz) are few of the major companies that come into play. Pfizer Inc, Green Cross Corp, Accord healthcare, Intas Pharmaceuticals Ltd, and Zydus Cadila are key participants too.
Ahmedabad based company, Intas Pharmaceutical ltd. Launched Azadine to benefit patients suffering from MDS and Acute Leukaemia.
Green Cross Corp collaborated with Aquavit Pharmaceuticals to develop and commercialize IBX-001 to personalize treatments and plasma-erivatives.
About the Report
This report offers a comprehensive market forecast of Pegfilgrastim biosimilars market. Global, regional and country-level representation of the top industry trends affecting the market is discussed in this FACT.MR study. The report offers insights on the market on the basis of channel (online, retail ), end user (biotechnology & pharmaceutical companies and contract research organizations) across regions (North America, Latin America, Europe, Asia Pacific, and MEA).
Media Release: https://www.factmr.com/media-release/1690/global-pegfilgrastim-biosimilar-market
The global rheumatology therapeutics market is highly competitive and consolidated due to presence of strong players, finds Transparency Market Research (TMR).
Some of the key players operating in the global rheumatology therapeutics market are AbbVie, Inc., Bristol-Myers Squibb Company, Pfizer, Inc., Merck & Co., Inc., Amgen, Inc., Novartis AG, Janssen Biotech, Inc., Sanofi, Genentech, Inc., and Takeda Pharmaceutical.
Among them, the companies such as AbbVie, Inc., Bristol-Myers Squibb Company, Pfizer, Inc., and Merck & Co., Inc. are accounts for the leading share in the global rheumatology therapeutics market.Strong expertise with attention to detail makes our market research reports stand apart, Request a Report sample @https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=1494TMR anticipated the global revenue of the rheumatology therapeutics market was registered in 2016 US$41.88 bn and expected to expand with a CAGR of 2.7% over the forecast period from 2017 to 2025 and expected to attain value of a US$ 52.96 bn by the end of 2025.
On the basis of drug class, the segment biologic DMARDs has registered at the revenue of US$35.83 bn in 2016 is expected to rise at a 2.6% CAGR with this growth rate in a revenue of US$45.06 bn by 2025.
On the basis of region, North America accounts for a leading share in the global rheumatology therapeutics market owing to rapid rise in the elderly population.Buy Rheumatology Therapeutics Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1494=S Rising Prevalence of Rheumatology Diseases to Boost GrowthRheumatology diseases generally effects on the supporting and connecting structures and bones of the body such as joints, muscles, ligaments, tendons and some of the organs of body.
Additionally, technological advancements in pharmaceutical field coupled with increasing investments in healthcare industry for research and development activities.
A recent study on the global Pegfilgrastim Biosimilar market has projected the revenues to rise to the worth of ~US$ 944 Mn in 2019.
The report highlights the key growth drivers and trends that will contribute to the growth momentum of the market.
The report provides an incisive analysis of the growth dynamics and quantitative assessment of the revenue potential in various regions and across key products, application/end-use industry, and technology segments.
It provides a comprehensive insight into the shares and sizes of the various segments in each year of the forecast period.
A comprehensive evaluation of recent investments by top players in the Pegfilgrastim Biosimilar market helps identify major research and development initiatives in the key regional markets.
The various assessments on the competitive landscape focus on the intensity of competition, entry barriers, PESTLE analysis, and key winning imperatives.
The new report on the Cutlery market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2015 – 2019.
The business intelligence study offers readers a granular assessment of key growth dynamics, promising avenues, and the competitive landscape of the Cutlery market.The novel Coronavirus (COVID-19) has caused a slowdown in business activities of the Cutlery Market.
With the help of our upcoming report, market players can gain important insights on alternative strategies that can help in revenue generation.
The leading factors that are likely to impact the growth of the Cutlery Market over the assessment period are thoroughly analyzed in the report.Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S_id=5201To offer a comprehensive assessment of opportunities, the study makes a scrutiny of growth prospects in various regions.
The key regions comprise the following geographical segments:North America (U.S., Canada)Latin America (Brazil, Mexico, Argentina, Rest of Latin America)Europe (Germany, Italy, France, U.K., Spain, Benelux, Russia, Rest of Europe)East Asia (China, Japan, South Korea)JapanAPEJ (China, India, Indonesia, Thailand, Singapore, Australia & New Zealand, Rest of Asia Pacific)South Asia & Oceania (India, Thailand, Indonesia, Malaysia, Australia & New Zealand, Rest of South Asia & Oceania)Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa, Rest of Middle East & Africa)The detailed assessments focus on, inter alia, on the regulatory and macroeconomic frameworks, prevailing pricing structure, imminent investment pockets, and emerging application areas.
Taking the analysis further, the study helps readers get a better understanding of the trends characteristics of the emerging markets, including government regulations crucial to growth of such markets.
Earwax removal aids are the medical tools used to remove earwax caused due to excessive formation of cerumen.
The earwax removal aid includes micro-suction device, earwax removal irrigation kits, earwax removal drops, earwax removal loops, earwax removal syringes, and portable ear cleaning devices.
According to the Fact.MR report, retail sales, especially in developing regions, is projected to show remarkable growth, due to easy availability of over-the-counter earwax removal aids.Request Sample Report - https://www.factmr.com/connectus/sample?flag=S_id=4100The healthcare industry is consistently witnessing an uplift in the number of ENT surgeries every year, globally, due to rising prevalence of ENT-related disorder.
This is the major factor responsible for the growth of the earwax removal aid market.Adult Age Group Remains the Target Population for ManufacturersUse of earwax removal kits among adults are likely to grow in the coming years, as carelessness, and negligence of cerumen impaction symptoms along with high adoption of self-diagnosis treatment continue to increase the risk of infection, affecting the ear-health adversely.
This trend of the social media platform has upsurge the awareness, and in turn, increased the treatment-seeking population.Preview Analysis of Global Earwax Removal Aid Market research report Segmented By Product Type (Micro-Suction Device, Ear Wax Removal Irrigation Kits, Ear Wax Removal Drops, Ear Wax Removal Loops, Ear Wax Removal Syringes, Portable Ear Cleaning Devices), By Age Group (Pediatric, Adults, Geriatric), By Distribution Channel, & by Region - https://www.factmr.com/report/4100/earwax-removal-aid-marketProduct Sales through Online Platforms to Boost the Market GrowthSale of products through online platforms such as Amazon, Flipkart, eBay, and others are gaining momentum among manufacturers, and are expected to drive the demand for earwax removal aid devices.
Also, costs of the earwax removal aids are very economical and many generic products are available in the earwax removal aids market.
Fact.MR’s Report on Global Pea Fiber MarketPea fiber is a byproduct which is extracted from the seeds and pods of a pea plant.
Pea fiber comprises high levels of protein, and does not contain any cholesterol either.
Consequently pea fiber is expected to gain traction around the world.Its nutritive properties has made pea fiber an increasingly popular ingredient in a number of pharmaceutical and food products.
The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin.
Prominent players covered in this research are Nutraonly (Xi'an) Nutritions Inc, G.S.
DUNN DRY MUSTARD MILLERS, Belle Pulses, Parrish & Heimbecker Limited, InterFiber, Quadra Chemicals, Cosucra, Vestkorn Milling AS, Farbest Brands, A Ingredients Inc., Puris Proteins, LLC, Emsland Group, Roquette Freres SA, AM Nutrition and Avena Foods, Limited.The pea fiber market report addresses the below-mentioned queries:Why are vendors shifting away from traditional methods of manufacturing pea fiber market?How does the global pea fiber market looks like in the next five years?Which end use industry is expected to surpass segment by the end of 2029?What innovative products are being introduced by the players in the global pea fiber market?Which regions are showing the fastest market growth?Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM_id=4312Pelletization and Backward Integration are Key StrategiesThe global market of pea fiber is largely consolidated in nature and a major share in terms of pea fiber is from major names such as Quadra Chemicals, Roquette Freres, Cosucra, Emsland Group, and Puris Proteins.Such major pea fiber producers are boosting their revenue through the use of new extraction and drying processes, with the aim of bolstering production capacities.
